• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease

摘要Objective:The development of culture-independent techniques for microbiological analysis shows that bronchial tree is not sterile in either healthy or chronic obstructive pulmonary disease (COPD) individuals.With the advance of sequencing technologies,lung microbiome has become a new frontier for pulmonary disease research,and such advance has led to better understanding of the lung microbiome in COPD.This review aimed to summarize the recent advances in lung microbiome,its relationships with COPD,and the possible mechanisms that microbiome contributed to COPD pathogenesis.Data Sources:Literature search was conducted using PubMed to collect all available studies concerning lung microbiome in COPD.The search terms were "microbiome" and "chronic obstructive pulmonary disease",or "microbiome" and "lung/pulmonary".Study Selection:The papers in English about lung microbiome or lung microbiome in COPD were selected,and the type of articles was not limited.Results:The lung is a complex microbial ecosystem;the microbiome in lung is a collection of viable and nonviable microbiota (bacteria,viruses,and fungi) residing in the bronchial tree and parenchymal tissues,which is important for health.The following types of respiratory samples are often used to detect the lung microbiome:sputum,bronchial aspirate,bronchoalveolar lavage,and bronchial mucosa.Disordered bacterial microbiome is participated in pathogenesis of COPD;there are also dynamic changes in microbiota during COPD exacerbations.Lung microbiome may contribute to the pathogenesis of COPD by manipulating inflammatory and/or immune process.Conclusions:Normal lung microbiome could be useful for prophylactic or therapeutic management in COPD,and the changes of lung microbiome could also serve as biomarkers for the evaluation of COPD.

更多
广告
作者单位 Department of Pulmonary and Critical Care Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100069, China [1] Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York 10001, USA [2] Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China [3]
栏目名称 Review Articles
DOI 10.4103/0366-6999.211452
发布时间 2017-09-27
基金项目
This study was supported by grams from the National Natural Science Foundation of China the Foundation of Chinese Ministry of Science and Technology the National Natural Science Foundation of Beijing
提交
  • 浏览38
  • 下载18
中华医学杂志(英文版)

中华医学杂志(英文版)

2017年130卷17期

2107-2111页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷